GQG Partners
GMAB icon

GQG Partners’s Genmab GMAB Stock Holding History

GQG Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,354
Closed -$627K – 91
2021
Q3 		$627K Hold
14,354
– – ﹤0.01% 67
2021
Q2 		$586K Buy
14,354
+3,293
+30% +$127K ﹤0.01% 62
2021
Q1 		$363K Sell
11,061
-7,985
-42% -$300K ﹤0.01% 60
2020
Q4 		$774K Buy
19,046
+1,117
+6% +$41.8K ﹤0.01% 53
2020
Q3 		$656K Buy
17,929
+108
+0.6% +$3.9K ﹤0.01% 61
2020
Q2 		$604K Buy
17,821
+8,309
+87% +$226K ﹤0.01% 56
2020
Q1 		$202K Hold
9,512
– – ﹤0.01% 58
2019
Q4 		$212K Buy
+9,512
New +$208K ﹤0.01% 55

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GQG Partners's GMAB Position: Q4 2021 in Review

GQG Partners sold out of Genmab (GMAB) in Q4 2021, closing a stake of 14,354 shares — an estimated $627K sold.

GQG Partners first reported a position in GMAB in Q4 2019 and held it in 8 quarters. The position peaked at $774K in Q4 2020. 211 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

  • GQG Partners reported no remaining Genmab position as of Q4 2021 after selling out during the quarter.
  • GQG Partners sold 14,354 Genmab shares in Q4 2021, an estimated $627K.
  • GQG Partners first reported a position in Genmab in Q4 2019 and held it in 8 quarters.
  • GQG Partners's Genmab position peaked at $774K in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on GQG Partners's 13F filing for Q4 2021, filed 14 Feb 2022.